Long, G. V., A. Hauschild, M. Santinami, V. Atkinson, M. Mandala, V. Chiarion-Sileni, J. Larkin, M. Nyakas, C. Dutriaux, A. Haydon, C. Robert, L. Mortier, J. Schachter, D. Schadendorf, T. Lesimple, R. Plummer, R. Ji, P. Zhang, B. Mookerjee, J. Legos, R. Kefford, R. Drummer, and J. M. Kirkwood. “Efficacy Outcomes in the Phase 3 COMBI-AD Study of Adjuvant Dabrafenib Plus Trametinib Vs Placebo in Patients With Stage III BRAFV600E/K-Mutant Melanoma”. SKIN The Journal of Cutaneous Medicine, vol. 2, no. S1, Feb. 2018, p. S43, doi:10.25251/skin.2.supp.43.